These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1593 related articles for article (PubMed ID: 33053993)

  • 1. [Long-term outcomes of patients undergoing hepatectomy for bilateral multiple colorectal liver metastases-a propensity score matching analysis].
    Bao Q; Wang K; Wang HW; Jin KM; Xing BC
    Zhonghua Wei Chang Wai Ke Za Zhi; 2020 Oct; 23(10):976-983. PubMed ID: 33053993
    [No Abstract]   [Full Text] [Related]  

  • 2. Bilobar versus unilobar multiple colorectal liver metastases: a propensity score analysis of surgical outcomes and recurrence patterns.
    Fukami Y; Kaneoka Y; Maeda A; Takayama Y; Takahashi T; Onoe S; Uji M; Wakai K
    J Hepatobiliary Pancreat Sci; 2017 Mar; 24(3):153-160. PubMed ID: 28054747
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Liver resection is justified for patients with bilateral multiple colorectal liver metastases: A propensity-score-matched analysis.
    Omichi K; Shindoh J; Cloyd JM; Mizuno T; Chun YS; Conrad C; Aloia TA; Tzeng CD; Vauthey JN
    Eur J Surg Oncol; 2018 Jan; 44(1):122-129. PubMed ID: 29208318
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Long-term and perioperative outcomes of laparoscopic versus open liver resection for colorectal liver metastases with propensity score matching: a multi-institutional Japanese study.
    Beppu T; Wakabayashi G; Hasegawa K; Gotohda N; Mizuguchi T; Takahashi Y; Hirokawa F; Taniai N; Watanabe M; Katou M; Nagano H; Honda G; Baba H; Kokudo N; Konishi M; Hirata K; Yamamoto M; Uchiyama K; Uchida E; Kusachi S; Kubota K; Mori M; Takahashi K; Kikuchi K; Miyata H; Takahara T; Nakamura M; Kaneko H; Yamaue H; Miyazaki M; Takada T
    J Hepatobiliary Pancreat Sci; 2015 Oct; 22(10):711-20. PubMed ID: 25902703
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Bilobar spreading of colorectal liver metastases does not significantly affect survival after R0 resection in the era of interdisciplinary multimodal treatment.
    Homayounfar K; Bleckmann A; Conradi LC; Sprenger T; Beissbarth T; Lorf T; Niessner M; Sahlmann CO; Meller J; Becker H; Liersch T; Ghadimi BM
    Int J Colorectal Dis; 2012 Oct; 27(10):1359-67. PubMed ID: 22430890
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prognostic impact of R1 resection margin in synchronous and simultaneous colorectal liver metastasis resection: a retrospective cohort study.
    Kim NR; Alhothaifi ED; Han DH; Choi JS; Choi GH
    World J Surg Oncol; 2023 Jun; 21(1):169. PubMed ID: 37280633
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Postoperative adjuvant chemotherapy is important for improving long-term survival in patients with colorectal cancer liver metastases undergoing simultaneous resection.
    Zhong W; Xu B; Lu Y; Chang J; Xu L; Zhao H; Che X
    J Gastroenterol Hepatol; 2024 May; 39(5):908-919. PubMed ID: 38323685
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Liver Resection in Synchronous Bilobar versus Unilobar Colorectal Liver Metastases: A Retrospective Analysis of Oncological Outcomes and Patient Survival.
    Stoess C; Mirschinka B; Ollesky J; Steffani M; Seyfried N; Kaufmann B; Friess H; Hüser N; Nitsche U; Hartmann D
    Dig Surg; 2024; 41(3):103-110. PubMed ID: 38705145
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Significance of postoperative adjuvant chemotherapy with an oxaliplatin-based regimen after simultaneous curative resection for colorectal cancer and synchronous colorectal liver metastasis: a propensity score matching analysis.
    Sugimoto K; Sakamoto K; Ii Y; Amemiya K; Sugo H; Ito T; Munakata S; Takahashi M; Kojima Y; Tomiki Y; Sato K; Saiura A; Kawasaki S
    BMC Surg; 2021 Apr; 21(1):188. PubMed ID: 33836701
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Liver-First Approach for Synchronous Colorectal Metastases: Analysis of 7360 Patients from the LiverMetSurvey Registry.
    Giuliante F; Viganò L; De Rose AM; Mirza DF; Lapointe R; Kaiser G; Barroso E; Ferrero A; Isoniemi H; Lopez-Ben S; Popescu I; Ouellet JF; Hubert C; Regimbeau JM; Lin JK; Skipenko OG; Ardito F; Adam R
    Ann Surg Oncol; 2021 Dec; 28(13):8198-8208. PubMed ID: 34212254
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Combined ablation and resection (CARe) for resectable colorectal cancer liver Metastases-A propensity score matching study.
    Liu M; Wang Y; Wang K; Bao Q; Wang H; Jin K; Liu W; Yan X; Xing B
    Eur J Surg Oncol; 2023 Sep; 49(9):106931. PubMed ID: 37183048
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Laparoscopic versus open two-stage hepatectomy for bilobar colorectal liver metastases: A bi-institutional, propensity score-matched study.
    Okumura S; Goumard C; Gayet B; Fuks D; Scatton O
    Surgery; 2019 Dec; 166(6):959-966. PubMed ID: 31395397
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Long-term survival in colorectal liver metastasis.
    She WH; Cheung TT; Tsang SHY; Dai WC; Lam KO; Chan ACY; Lo CM
    Langenbecks Arch Surg; 2022 Dec; 407(8):3533-3541. PubMed ID: 36018430
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Laparoscopic two-stage hepatectomy for bilobar colorectal liver metastases.
    Fuks D; Nomi T; Ogiso S; Gelli M; Velayutham V; Conrad C; Louvet C; Gayet B
    Br J Surg; 2015 Dec; 102(13):1684-90. PubMed ID: 26392212
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Optimal surgical sequence for colorectal cancer liver metastases patients receiving colorectal cancer resection with simultaneous liver metastasis resection: A multicentre retrospective propensity score matching study.
    Chen Q; Zhang R; Xing B; Li C; Xiu D; Chen J; Deng Y; Chen X; Guo R; Chen F; Peng J; Sun T; Wang H; Li M; Zheng Q; Bi X; Zhao J; Zhou J; Li Z; Huang Z; Zhang Y; Zhang Y; Cai J; Zhao H
    Int J Surg; 2022 Oct; 106():106952. PubMed ID: 36220519
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Parenchymal-sparing hepatectomy for colorectal liver metastases reduces postoperative morbidity while maintaining equivalent oncologic outcomes compared to non-parenchymal-sparing resection.
    Andreou A; Gloor S; Inglin J; Di Pietro Martinelli C; Banz V; Lachenmayer A; Kim-Fuchs C; Candinas D; Beldi G
    Surg Oncol; 2021 Sep; 38():101631. PubMed ID: 34298267
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Primary tumor location affects recurrence-free survival for patients with colorectal liver metastases after hepatectomy: a propensity score matching analysis.
    Zhang Y; Wang Y; Yuan Y; Qiu J; Qiu Y; He W; Zheng Y; Wang Z; Gu Y; Lu Z; Chen G; Ding P; Wu X; Pan Z; Wan D; Li Y; Xu R; Yuan Y; Li B
    World J Surg Oncol; 2020 May; 18(1):98. PubMed ID: 32423450
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Right and extended-right hepatectomies for unilobar colorectal metastases: impact of portal vein embolization on long-term outcome and liver recurrence.
    Ardito F; Vellone M; Barbaro B; Grande G; Clemente G; Giovannini I; Federico B; Bonomo L; Nuzzo G; Giuliante F
    Surgery; 2013 Jun; 153(6):801-10. PubMed ID: 23701876
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impact of Surgical Treatment for Recurrence After 2-Stage Hepatectomy for Colorectal Liver Metastases, on Patient Outcome.
    Imai K; Benitez CC; Allard MA; Vibert E; Cunha AS; Cherqui D; Castaing D; Bismuth H; Baba H; Adam R
    Ann Surg; 2019 Feb; 269(2):322-330. PubMed ID: 28820745
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hepatic resection combined with radiofrequency ablation for initially unresectable colorectal liver metastases after effective chemotherapy is a safe procedure with a low incidence of local recurrence.
    Mima K; Beppu T; Chikamoto A; Miyamoto Y; Nakagawa S; Kuroki H; Okabe H; Hayashi H; Sakamoto Y; Watanabe M; Kikuchi K; Baba H
    Int J Clin Oncol; 2013 Oct; 18(5):847-55. PubMed ID: 22940848
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 80.